SCI Abstract

search
+
Pre-clinical phaeochromocytoma and paraganglioma models: Cell lines, animal models, and a human primary culture model
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b91cbd2f941-...
Personalized management for phaeochromocytomas and paragangliomas in Latin America: A genetic perspective
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b8b0cbd67ff-...
The current and upcoming era of radiomics in phaeochromocytoma and paraganglioma
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b816de1ceb1-...
SDH-related head and neck paragangliomas: Unraveling PET radiomics beyond 18F-FDG
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b79fa7767d3-...
Recent discoveries of Sino-Caucasian differences in the genetics of phaeochromocytomas and paragangliomas
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b734abff9dc-...
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b6ccc2c1637-...
Transgender
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b5f3ebacfd5-...
Testosterone and other treatments for transgender males and non-binary trans masculine individuals
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b55dce0cfcc-...
Testosterone-induced erythrocytosis in transgender males: Challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications for prescribing SGLT2 inhibitor drugs
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b4f1ca215df-...
Gender-affirming hormone treatment modalities for transfemale & non-binary transfeminine individuals: A UK perspective
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b487d53155d-...
Metabolic and cardiovascular risks of hormone treatment for transgender individuals
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b41bbdc9658-...
The implications of hormone treatment for cancer risk, screening and treatment in transgender individuals
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b3a5e2415c6-...
Clinical considerations and endocrinological implications in the detransition process
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b33e90bfa36-...
Metabolomics and proteomics in pheochromocytoma/paraganglioma: translating biochemistry and biology to bedside
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b2c9c7f169a-...
Overview of recent guidelines and consensus statements on initial screening and management of phaeochromocytoma and paraganglioma in SDHx pathogenic variant carriers and patients
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b260ea8982e-...
Recent progress in molecular classification of phaeochromocytoma and paraganglioma
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b1f3d3f985a-...
Head and neck paragangliomas: recent advances in translational and clinical research and guidelines for patient care
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b188c011703-...
Role of B cells in intratumoral MBTA immunotherapy of murine pheochromocytoma model
Update your browser to view ScienceDirect. View recommended browsers. Request details: Request ID: 8c232b1119857e30-...
Real-world value of cabergoline in the treatment of acromegaly
Real-world value of cabergoline in the treatment of acromegaly
Acromegaly is a chronic condition caused by a growth hormone (GH)-secreting pituitary adenoma leading to excess production...
Revisiting hypophosphatemic rickets/osteomalacia
Revisiting hypophosphatemic rickets/osteomalacia
Cookies are used by this site. Cookie SettingsAll content on this site: Copyright © 2024 Elsevier B.V., its licensors, an...
Vitamin D deficiency or resistance and hypophosphatemia
Vitamin D deficiency or resistance and hypophosphatemia
Vitamin D, is mainly produced in the skin by sun exposure. On exposure to ultraviolet B (∼290–315 nm) sun-rays, 7-dehydroc...
Predictors of biochemical response to somatostatin receptor ligands in acromegaly
Predictors of biochemical response to somatostatin receptor ligands in acromegaly
Although predictors of response to first-generation somatostatin receptor ligands (fg-SRLs), and to a lesser extent to pas...
Efficacy and safety of radiosurgery in acromegaly
Efficacy and safety of radiosurgery in acromegaly
Pituitary adenomas originate from the endocrine tissue of the adenohypophysis and are the most common sellar lesions (acco...
Preface to the Special issue: Diagnosis and treatment of acromegaly, a paradigmatic disease
Preface to the Special issue: Diagnosis and treatment of acromegaly, a paradigmatic disease
Cookies are used by this site. Cookie SettingsAll content on this site: Copyright © 2024 Elsevier B.V., its licensors, an...
“Micromegaly”: Acromegaly with apparently normal GH, an entity on its own?
“Micromegaly”: Acromegaly with apparently normal GH, an entity on its own?
Acromegaly is a rare and underdiagnosed disorder caused, in more than 95% of cases, by a growth hormone (GH)-secreting pit...
Histopathology of growth hormone-secreting pituitary tumors: State of the art and new perspectives
Histopathology of growth hormone-secreting pituitary tumors: State of the art and new perspectives
Pituitary adenomas (PAs)/Pituitary Neuroendocrine Tumors (PitNETs) are a very heterogenous group of tumors in terms of cli...
Genetic diagnosis in acromegaly and gigantism: From research to clinical practice
Genetic diagnosis in acromegaly and gigantism: From research to clinical practice
It is usually considered that only 5% of all pituitary neuroendocrine tumours are due to inheritable causes. Since this es...
The clinical and biochemical spectrum of ectopic acromegaly
The clinical and biochemical spectrum of ectopic acromegaly
Cookies are used by this site. Cookie SettingsAll content on this site: Copyright © 2024 Elsevier B.V., its licensors, an...
The molecular biology of sporadic acromegaly
The molecular biology of sporadic acromegaly
Acromegaly/gigantism is characterized by increased levels of growth hormone (GH) and the effector of most of its biologica...
The pathophysiology of hypophosphatemia
The pathophysiology of hypophosphatemia
The level of serum phosphate (Pi) is tightly regulated to remain in the optimal range. However, long-term disruption of th...
Load More
format_indent_increase